| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |